Pages that link to "Q204727"
Jump to navigation
Jump to search
The following pages link to Alexion Pharmaceuticals (Q204727):
Displayed 50 items.
- Alexion Pharma (Switzerland) (Q43896121) (← links)
- Douglas P. Gladue (Q49912585) (← links)
- William Mowrey (Q57336611) (← links)
- Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome (Q61894568) (← links)
- Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma (Q61918500) (← links)
- Children With Lysosomal Acid Lipase Deficiency Who Previously Received Treatment With SBC-102 (Q61955311) (← links)
- Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects (Q61966213) (← links)
- Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) (Q61969542) (← links)
- Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH) (Q61980852) (← links)
- Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II) (Q62110268) (← links)
- Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP) (Q63062409) (← links)
- Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP) (Q63062931) (← links)
- Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor (Q63318122) (← links)
- Atypical Hemolytic-Uremic Syndrome (aHUS) Registry (Q63319884) (← links)
- aHUS Observational Long Term Follow-Up (Q63319887) (← links)
- A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP) (Q63322523) (← links)
- A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype (Q63336049) (← links)
- Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH) (Q63336276) (← links)
- A Phase 3, Open-Label Study of ALXN1210 in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria (PNH) (Q63404202) (← links)
- An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP) (Q63571411) (← links)
- Lysosomal Acid Lipase (LAL) Deficiency Registry (Q63590982) (← links)
- A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) (Q63592604) (← links)
- Kenneth Pomerantz (Q68233391) (← links)
- Daria V. Sizova (Q73709511) (← links)
- Olivia Tong (Q83707701) (← links)
- Cory A King (Q85216651) (← links)
- Cristina Costa (Q87819730) (← links)
- Francesca Cicchetti (Q89283451) (← links)
- Fanny O'Brien (Q90440114) (← links)
- Ketaki Deshpande (Q92404359) (← links)
- Peter Hjelmström (Q92500232) (← links)
- Sabyasachi Dash (Q96002375) (← links)
- Luis Briseño-Roa (Q96243043) (← links)
- Amy Pace (Q97522720) (← links)
- Cory Williams (Q125356251) (← links)
- Bis-choline tetrathiomolybdate for treating Wilson disease (Q125790972) (← links)
- Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof (Q125790978) (← links)
- Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patients (Q125790995) (← links)
- Cerdulatinib for treating hematological cancers (Q125791015) (← links)
- Anti-C5 antibodies having improved pharmacokinetics (Q125791018) (← links)
- Bis-choline tetrathiomolybdate for treating Wilson Disease (Q125791025) (← links)
- Inhibitors of protein kinases (Q125791032) (← links)
- Anti-C5A antibodies (Q125791036) (← links)
- Methods for treating lysosomal acid lipase deficiency in patients (Q125791041) (← links)
- Methods for treating craniosynostosis in a patient (Q125791047) (← links)
- High concentration anti-C5 antibody formulations (Q125791066) (← links)
- Manufacturing of alkaline phosphatases (Q125791075) (← links)
- Synthesis of cerdulatinib (Q125791090) (← links)
- Methods for treating lymphoma (Q125791150) (← links)
- Bone delivery conjugates and method of using same to target proteins to bone (Q125791169) (← links)